南方医科大学学报 ›› 2015, Vol. 35 ›› Issue (09): 1239-.

• • 上一篇    下一篇

双功能分子白介素-2-粒细胞-巨噬细胞集落生长因子促进树突状细胞在肿瘤免疫抑制环境中的活化效应

温茜,熊文景,刘苏东,周超颖,马骊   

  • 出版日期:2015-09-20 发布日期:2015-09-20

Effect of bifunctional IL2-GMCSF in promoting dendritic cell activation in vitro in
simulated tumor-induced immune suppression

  • Online:2015-09-20 Published:2015-09-20

摘要: 目的将本室构建与制备的双功能分子白介素-2-粒细胞-巨噬细胞集落生长因子(IL2-GMCSF)蛋白作用于肿瘤条件培养
基(TCM)环境中的树突状细胞系(DC),检测其对DC细胞的活化,探讨其用于活化DC、进行抗肿瘤免疫治疗的可能性。方法
制备小鼠黑色素瘤B16F10 细胞系的TCM,用以培养DC2.4 细胞,同时分别添加IL2-GMCSF、GM-CSF、IL-2、或IL-2 与
GM-CSF组合使用。24 h后,检测DC2.4细胞的吞噬与增殖活性、细胞成熟表型、细胞因子分泌与信号通路活化。结果DC2.4
细胞具有未成熟DC的特征,在TCM培养条件下吞噬能力增强、但增殖活性显著受抑,TCM对DC成熟表型表面标志的表达有
一定促进作用,并促进单核与DC来源的趋化因子(MDC),但抑制DC的IL-12 分泌。与之相反,IL2-GMCSF 主要借助其
GM-CSF 活性,促进DC2.4 细胞的吞噬与增殖活性,并促进DC 进一步成熟,且高表达IL-12 与MDC。与GM-CSF 相比,
IL2-GMCSF可诱导更高的炎性NF-κB通路活化水平,而抑制调节性STAT3 通路的活化。结论与GM-CSF单独作用相比,
IL2-GMCSF可更好地促进肿瘤免疫抑制环境中的DC活化,有望成为有效的临床抗肿瘤治疗手段。

Abstract: Objective To test the effect of bifunctional molecule IL2-GMCSF in promoting the activation of dendritic cells (DCs)
cultured in tumor conditioned medium. Methods We prepared a tumor conditioned medium using mouse melanoma cell line
B16F10 supplemented with IL2-GMCSF, GM-CSF, IL-2, or the combination of the latter two. After culturing mouse DC cell line
DC2.4 in the conditioned medium for 24 h, the DCs were examined for phagocytosis, proliferation, maturation phenotype,
cytokine secretion, and signal pathway activation. Results DC2.4 cells displayed characteristics of immature DCs. After cell
culture in the conditioned medium, the cells showed enhanced phagocytosis but significantly suppressed cell proliferation
activity. Culture in the conditioned medium also promoted DC cell maturation and secretion of macrophage-derived
chemokine (MDC), but inhibited IL-12 secretion. Supplementation of the conditioned medium with IL2-GMCSF promoted
phagocytosis, proliferation, maturation, and cytokine (including both IL-12 and MDC) secretion of DC2.4 cells. Compared with
GM-CSF, IL2-GMCSF induced a higher level of NF-κB signal pathway activation but suppressed STAT3 activation. Conclusion
Compared with GM-CSF, IL2-GMCSF can better promote DC activation in the context of tumor-induced immune suppression,
and thus shows potentials in anti-tumor therapy.